Rocket


Overview
Financials
News + Filings

 
 

VACCINEX, INC. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16
Revenues0.10.3
            Revenue growth-71.5% 
Cost of goods sold0.20.1
Gross profit-0.10.2
            Gross margin-77.8%63.6%
Research and development16.616.0
General and administrative4.54.4
EBIT-21.1-20.3
            EBIT margin-23448.9%-6411.1%
Pre-tax income-18.8-13.9
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-18.7-13.9
            Net margin-20802.2%-4412.3%
 
Diluted EPS($21,933.00)($26,233.00)
Shares outstanding (diluted)0.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy